Protech is participating in the EUREKA II project, implemented by the Research Council of Lithuania (LMT) together with the Central Project Management Agency (CPVA). The aim of the project is to increase the internationalisation of science by promoting market-oriented research and experimental development (R&D) projects carried out by academia and business through the transnational EUREKA network.
The total value of the project is EUR 951,068.68. The project duration is from 20 January 2026 to 31 January 2029.
The project aims to encourage more active participation of Lithuanian research and higher education institutions, as well as small and medium-sized enterprises, in international R&D programmes and to better utilise their potential in developing high-level innovative products. International networking will be strengthened, the number of high-quality EUREKA network R&D projects will increase, and the continuity of Lithuanian partners’ participation in international consortia will be ensured.
The project also seeks to raise awareness of the EUREKA programme in Lithuania, organise expert training, and more actively disseminate information about Lithuania’s scientific capabilities at the international level. The project is targeted at research and higher education institutions and micro, small and medium-sized enterprises that, together with foreign partners, will implement EUREKA network projects — from prototype or model validation to the evaluation of newly developed products.
The project is implemented together with the following partners: UAB “Taikomasis dirbtinis intelektas”, UAB “Modernios E-Technologijos”, Vilnius University, and UAB “EDIS Lab”. Through joint efforts, the project aims to strengthen Lithuania’s innovation ecosystem and create more favourable conditions for the country’s researchers and companies to actively participate in international R&D initiatives.
The 2022–2030 Development Programme is administered by the Ministry of Education, Science and Sport of the Republic of Lithuania. The project is co-funded by the European Union.
